LY3541105

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3541105, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3541105 in Healthy and Overweight Participants [Phase 1]